Clinical Orthopaedics and Related Research®

, Volume 472, Issue 3, pp 865–873

Chick Embryo Extract Demethylates Tumor Suppressor Genes in Osteosarcoma Cells

  • Xiaodong Mu
  • Bolat Sultankulov
  • Riddhima Agarwal
  • Adel Mahjoub
  • Trevor Schott
  • Nicholas Greco
  • Johnny Huard
  • Kurt Weiss
Symposium: Musculoskeletal Tumor Society 2012 Symposium

DOI: 10.1007/s11999-013-3104-6

Cite this article as:
Mu, X., Sultankulov, B., Agarwal, R. et al. Clin Orthop Relat Res (2014) 472: 865. doi:10.1007/s11999-013-3104-6

Abstract

Background

Epigenetics is the study of changes in gene expression or cellular phenotype caused by mechanisms other than changes in the underlying DNA sequence. It is widely accepted that cancer has genetic and epigenetic origins. The idea of epigenetic reprogramming of cancer cells by an embryonic microenvironment possesses potential interest from the prospect of both basic science and potential therapeutic strategies. Chick embryo extract (CEE) has been used for the successful expansion of many specific stem cells and has demonstrated the ability to facilitate DNA demethylation.

Questions/purposes

The current study was conducted to compare the status of DNA methylation in highly metastatic and less metastatic osteosarcoma cells and to investigate whether CEE may affect the epigenetic regulation of tumor suppressor genes and thus change the metastatic phenotypes of highly metastatic osteosarcoma cells.

Methods

K7M2 murine OS cells were treated with CEE to determine its potential effect on DNA methylation, cell apoptosis, and invasion capacity.

Results

Our current results suggest that the methylation status of tumor suppressor genes (p16, p53, and E-cadherin) is significantly greater in highly metastatic mouse ostoesarcoma K7M2 cells in comparison with less metastatic mouse osteosarcoma K12 cells. CEE treatment of K7M2 cells caused demethylation of p16, p53, and E-cadherin genes, upregulated their expression, and resulted in the reversion of metastatic phenotypes in highly metastatic osteosarcoma cells.

Conclusions

CEE may promote the reversion of metastatic phenotypes of osteosarcoma cells and can be a helpful tool to study osteosarcoma tumor reversion by epigenetic reprogramming.

Clinical Relevance

Demethylation of tumor suppressor genes in osteosarcoma may represent a novel strategy to diminish the metastatic potential of this neoplasm. Further studies, both in vitro and in vivo, are warranted to evaluate the clinical feasibility of this approach as an adjuvant to current therapy.

Copyright information

© The Association of Bone and Joint Surgeons® 2013

Authors and Affiliations

  • Xiaodong Mu
    • 1
  • Bolat Sultankulov
    • 2
  • Riddhima Agarwal
    • 1
  • Adel Mahjoub
    • 1
  • Trevor Schott
    • 1
  • Nicholas Greco
    • 1
  • Johnny Huard
    • 1
  • Kurt Weiss
    • 1
  1. 1.Cancer Stem Cell Laboratory, Stem Cell Research Center, Department of Orthopaedic SurgeryUniversity of PittsburghPittsburghUSA
  2. 2.Department of BiophysicsNazarbayev University Research and Innovation SystemAstanaKazakhstan